Literature DB >> 33738605

The effect of calibration factors and recovery coefficients on 177Lu SPECT activity quantification accuracy: a Monte Carlo study.

Keamogetswe Ramonaheng1, Johannes A van Staden2, Hanlie du Raan2.   

Abstract

BACKGROUND: Different gamma camera calibration factor (CF) geometries have been proposed to convert SPECT data into units of activity concentration. However, no consensus has been reached on a standardised geometry. The CF is dependent on the selected geometry and is further affected by partial volume effects. This study investigated the effect of two CF geometries and their corresponding recovery coefficients (RCs) on the quantification accuracy of 177Lu SPECT images using Monte Carlo simulations.
METHODS: The CF geometries investigated were (i) a radioactive-sphere surrounded by non-radioactive water (sphere-CF) and (ii) a cylindrical phantom uniformly filled with radioactive water (cylinder-CF). Recovery coefficients were obtained using the sphere-CF and cylinder-CF, yielding the sphere-RC and cylinder-RC values, respectively, for partial volume correction (PVC). The quantification accuracy was evaluated using four different-sized spheres (15.6-65.4 ml) and a kidney model with known activity concentrations inside a cylindrical, torso and patient phantom. Images were reconstructed with the 3D OS-EM algorithm incorporating attenuation, scatter and detector-response corrections. Segmentation was performed using the physical size and a small cylindrical volume inside the cylinder for the sphere-CF and cylinder-CF, respectively.
RESULTS: The sphere quantification error (without PVC) was better for the sphere-CF (≤ - 5.54%) compared to the cylinder-CF (≤ - 20.90%), attributed to the similar geometry of the quantified and CF spheres. Partial volume correction yielded comparable results for the sphere-CF-RC (≤ 3.47%) and cylinder-CF-RC (≤ 3.53%). The accuracy of the kidney quantification was poorer (≤ 22.34%) for the sphere-CF without PVC compared to the cylinder-CF (≤ 2.44%). With PVC, the kidney quantification results improved and compared well for the sphere-CF-RC (≤ 3.50%) and the cylinder-CF-RC (≤ 3.45%).
CONCLUSION: The study demonstrated that upon careful selection of CF-RC combinations, comparable quantification errors (≤ 3.53%) were obtained between the sphere-CF-RC and cylinder-CF-RC, when all corrections were applied.

Entities:  

Keywords:  177Lu; Calibration factor; Monte Carlo; Quantification; Recovery coefficients; SIMIND

Year:  2021        PMID: 33738605      PMCID: PMC7973313          DOI: 10.1186/s40658-021-00365-8

Source DB:  PubMed          Journal:  EJNMMI Phys        ISSN: 2197-7364


  55 in total

1.  A Monte Carlo and physical phantom evaluation of quantitative In-111 SPECT.

Authors:  Bin He; Yong Du; Xiyun Song; W Paul Segars; Eric C Frey
Journal:  Phys Med Biol       Date:  2005-08-24       Impact factor: 3.609

Review 2.  Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications.

Authors:  Sharmila Banerjee; M R A Pillai; F F Russ Knapp
Journal:  Chem Rev       Date:  2015-04-13       Impact factor: 60.622

3.  Quantitative 177Lu SPECT imaging using advanced correction algorithms in non-reference geometry.

Authors:  M D'Arienzo; M L Cozzella; A Fazio; P De Felice; G Iaccarino; M D'Andrea; S Ungania; M Cazzato; K Schmidt; S Kimiaei; L Strigari
Journal:  Phys Med       Date:  2016-09-28       Impact factor: 2.685

4.  MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy.

Authors:  Yuni K Dewaraja; Eric C Frey; George Sgouros; A Bertrand Brill; Peter Roberson; Pat B Zanzonico; Michael Ljungberg
Journal:  J Nucl Med       Date:  2012-06-28       Impact factor: 10.057

5.  A Monte Carlo program for the simulation of scintillation camera characteristics.

Authors:  M Ljungberg; S E Strand
Journal:  Comput Methods Programs Biomed       Date:  1989-08       Impact factor: 5.428

6.  Quantitative SPECT/CT Imaging of (177)Lu with In Vivo Validation in Patients Undergoing Peptide Receptor Radionuclide Therapy.

Authors:  J C Sanders; T Kuwert; J Hornegger; P Ritt
Journal:  Mol Imaging Biol       Date:  2015-08       Impact factor: 3.488

7.  Peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE: the IEO phase I-II study.

Authors:  Lisa Bodei; Marta Cremonesi; Chiara M Grana; Nicola Fazio; Simona Iodice; Silvia M Baio; Mirco Bartolomei; Dario Lombardo; Mahila E Ferrari; Maddalena Sansovini; Marco Chinol; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-03       Impact factor: 9.236

8.  Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment.

Authors:  Mattias Sandström; Ulrike Garske-Román; Dan Granberg; Silvia Johansson; Charles Widström; Barbro Eriksson; Anders Sundin; Hans Lundqvist; Mark Lubberink
Journal:  J Nucl Med       Date:  2012-12-07       Impact factor: 10.057

9.  Optimization of image reconstruction method for SPECT studies performed using [⁹⁹mTc-EDDA/HYNIC] octreotate in patients with neuroendocrine tumors.

Authors:  Anna Sowa-Staszczak; Wioletta Lenda-Tracz; Monika Tomaszuk; Bogusław Głowa; Alicja Hubalewska-Dydejczyk
Journal:  Nucl Med Rev Cent East Eur       Date:  2013

10.  Improving quantitative dosimetry in (177)Lu-DOTATATE SPECT by energy window-based scatter corrections.

Authors:  Robin de Nijs; Vera Lagerburg; Thomas L Klausen; Søren Holm
Journal:  Nucl Med Commun       Date:  2014-05       Impact factor: 1.690

View more
  1 in total

1.  Accuracy of two dosimetry software programs for 177Lu radiopharmaceutical therapy using voxel-based patient-specific phantoms.

Authors:  Keamogetswe Ramonaheng; Johannes A van Staden; Hanlie du Raan
Journal:  Heliyon       Date:  2022-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.